Fig. 3. Disease-free survival (DFS) and overall survival (OS) in relation to FAT4 expression in gastric cancer. (A) The loss of FAT4 expression was significantly associated with poor DFS (5-year survival rate; loss vs. no loss, 68.7% vs. 86.9%, P=0.017). (B) The FAT4-negative group was associated with poor OS, but statistical significance was borderline (5-year survival rate; loss vs. no loss, 57.6% vs. 70.9%, P=0.083). ^*P<0.05.